Theralase raises up to C$4M in private placement to fund cancer and virus treatment trials

Theralase files prospectus to raise up to C$100M for cancer and virus drug development

Theralase Technologies Inc. has filed a final base shelf prospectus allowing it to raise up to C$100 million over 25 months through the sale of various securities. This funding will support the development of its cancer, virus, and bacteria treatment...